STOCKHOLDERS’ DEFICIT (Tables)

12 Months Ended

Sep. 30, 2023

Stock option activities for the years ended September 30, 2023 and 2022 are summarized as follows:

SCHEDULE OF STOCK OPTION ACTIVITY

	Number of Options			Weighted Average Exercise Price
Balance Outstanding September 30, 2021		-			-
Granted		1,901,410,519			0.0036
Forfeited/Expired		-			-
Balance Outstanding September 30, 2022		1,901,410,519			0.0036
Granted		-			-
Forfeited/Expired		(237,139,599	)		0.0036
Balance Outstanding September 30, 2023		1,664,270,920			0.0036
Exercisable, September 30, 2023 (a)		1,568,866,805			0.0036

The following table summarizes additional information on the Company’s stock options outstanding at September 30, 2023:

Options Outstanding								Options Exercisable (a)
Exercise Price		Number Outstanding		Weighted Average Remaining Contractual Term (Years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
	0.0036		1,664,270,920		8.88		0.0036		1,568,866,805		0.0036

(a)	All vested options are only exercisable upon the company filing an S-8 to register the underlying shares.

Warrants activities for the years ended September 30, 2023 and 2022, are summarized as follows:

SCHEDULE OF WARRANTS

			Weighted		Weighted Average Remaining
			Average		Contractual		Aggregate
	Number of		Exercise		Term		Intrinsic
	Warrants		Price		(Years)		Value
Balance Outstanding on September 30, 2021		984,470,116	$	0.0023		3.50	$	-

Issued in connection with a convertible debt – related party (see Note 7 and Note 9)		321,543,374		0.0038		4.16

Issued in connection with a convertible debt (see Note 7)		582,799,515		0.0037		4.09

Balance Outstanding on September 30, 2022		1,888,813,005		0.0030		3.26		1,140,362

Issued in connection with a New Related Party Convertible Debentures (see Note 6)		2,608,654,988		0.003		5.0

Issued in connection with a New Convertible Debentures (see Note 6)		2,567,601,521		0.003		5.0
Issued to placement agent and consultant in connection with New Related Party and New Convertible Debentures (see Note 6)		179,265,305		0.003		5.0
Balance Outstanding on September 30, 2023		7,244,334,819	$	0.0011		4.78	$	1,665,567
Exercisable on September 30, 2023		7,044,334,819	$	0.0011		4.86	$	1,665,567

THERALINK TECHNOLOGIES, INC. 10-K